Authors/Disclosures
|
Lumine Matsumoto, MD, PhD
(University of Tokyo)
|
No disclosure on file |
|
Robert Yao
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Mana Higashihara, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Neel Mehta, Neel Mehta
(EpiFinder Inc.)
|
No disclosure on file |
|
Hisatomo Kowa, MD, PhD
(Kobe Univ Graduate School of Health Sciences)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jun Goto, MD, PhD
(International University of Health and Welfare Ichikawa Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Josep O. Dalmau, MD, PhD, FAAN
|
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
|
Shoji Tsuji, MD, PhD
(University of Tokyo)
|
The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd.. |